Session » Health Services Research Poster II: Care Models and Innovation (1061–1082)

Date: Monday, November 8, 2021

Time: 8:30AM-10:30AM

Meeting: ACR Convergence 2021

8:30AM-10:30AM: Abstract Number: 1079

A Multifaceted Approach to Increasing Enrollment and Activation of Pediatric Rheumatology Patient Portal Profiles

8:30AM-10:30AM: Abstract Number: 1068

Analysis of Tweets Containing Information Related to Rheumatological Diseases on Twitter

8:30AM-10:30AM: Abstract Number: 1076

Combining Fuzzy Logic with Time-Driven Activity Based Costing Within the Rheumatoid Arthritis Care Cycle: Insights from a Dutch Hospital

8:30AM-10:30AM: Abstract Number: 1061

Comparing Consultation Patterns Across Telehealth Platforms and Face-to-Face Clinic in the Military Health System

8:30AM-10:30AM: Abstract Number: 1080

Effect of Triage by a Rheumatologist in a Primary Care Setting

8:30AM-10:30AM: Abstract Number: 1077

Effectiveness of Non-Pharmacological Interventions to Promote Work Participation of People with Rheumatic and Musculoskeletal Diseases: A Systematic Review and Meta-Regression Analysis

8:30AM-10:30AM: Abstract Number: 1066

Evaluation of a Non-Face to Face Multidisciplinary Health Care Model in a Population with Rheumatoid ArthritisVulnerable to Covid-19 in a Health Emergency Situation

8:30AM-10:30AM: Abstract Number: 1067

Experiences of Self-Care During the COVID-19 Pandemic Among Individuals with Rheumatoid Arthritis: A Qualitative Study

8:30AM-10:30AM: Abstract Number: 1070

Experiences of Wearable Technology by Persons with Knee Osteoarthritis Participating in a Physical Activity Counselling Intervention Study: A Relational Ethics Lens

8:30AM-10:30AM: Abstract Number: 1071

Experiences Using Wearable Technology by Persons with Rheumatoid Arthritis Participating in a Physical Activity Counselling Intervention Study: A Relational Ethics Analysis

8:30AM-10:30AM: Abstract Number: 1081

Improving Rheumatology Resource Utilization and Access to Specialty Care for Patients with Early Inflammatory Arthritis Through Enhanced Triage

8:30AM-10:30AM: Abstract Number: 1073

In Favor of the Subspecialty Clinic Model for Rheumatoid Arthritis

8:30AM-10:30AM: Abstract Number: 1065

Optimizing Joint Pain EConsult Referrals in an Underserved Region of Southern California

8:30AM-10:30AM: Abstract Number: 1064

Pharmacist-Led Multidisciplinary Approach to Opioid Tapering in a Private Rheumatology Practice: Patient Outcomes

8:30AM-10:30AM: Abstract Number: 1078

Rural Veterans with Gout – “Rheum” for Improvement

8:30AM-10:30AM: Abstract Number: 1074

Satisfaction with a Virtual Learning Collaborative Aimed at Implementing Treat to Target (TTT) in Rheumatoid Arthritis (RA)

8:30AM-10:30AM: Abstract Number: 1069

Supporting Patient-Centered Care in the Pediatric Rheumatology Setting: Patient, Family and Provider Experiences with OurNotes

8:30AM-10:30AM: Abstract Number: 1062

Telemedicine Enriched Care Model to Optimize Care for Patients with Autoinflammatory Diseases

8:30AM-10:30AM: Abstract Number: 1075

The Impact of an Integrated Care Management Program on Acute Care Use for Potentially Avoidable Conditions Among High-Risk Patients with SLE

8:30AM-10:30AM: Abstract Number: 1072

The Multidisciplinary Approach with Patient Collaboration Improve the Clinical Effectiveness of the Intervention

8:30AM-10:30AM: Abstract Number: 1082

The Rheumatology Workforce in Canada: Results of the Workforce and Wellness Survey

8:30AM-10:30AM: Abstract Number: 1063

Use of Telemedicine for Rheumatology Practice in Queensland, Australia: Experiences Before and During the COVID-19 Pandemic

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].